ChengDu, China

Tao K Xu

This inventor holds 1 USPTO granted patent. Top assignee: Sichuan Baili Pharmaceutical Co., Ltd. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tao K Xu. Retrieved from https://idiyas.com/inventor/tao-k-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tao K Xu

Introduction

Tao K Xu is a prominent inventor based in ChengDu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on drug derivatives. His expertise and dedication to research have led to the development of valuable patents that enhance medical treatments.

Latest Patents

One of Tao K Xu's notable patents is the "Camptothecin Derivative and Conjugate Thereof." This invention represents a significant advancement in cancer treatment, showcasing his commitment to improving therapeutic options for patients.

Career Highlights

Tao K Xu is currently employed at Sichuan Baili Pharmaceutical Co., Ltd. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of new pharmaceutical products. His work has garnered attention within the industry, highlighting his importance as an inventor.

Collaborations

Tao K Xu has collaborated with several talented individuals in his field, including Yi Zhu and Weili Wan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Tao K Xu's contributions to the pharmaceutical industry through his patent and collaborative efforts demonstrate his dedication to advancing medical science. His work continues to impact the field positively, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…